BridgeBio's Approach To Gene Therapy & Nearing The Clinic With Dr. Eric David

Source: Cell & Gene

BridgeBio's CEO of Gene Therapy, Dr. Eric David, explains the company's gene therapy programs for Canavan disease and congenital adrenal hyperplasia, their manufacturing plans, and the platform underpinning their approach to gene therapy.